Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07098481 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Access to Hepatitis C Treatment in Cameroon: Comparison of a Simplified Test and Treat Strategy to a Standard Strategy

Study acronym: ACCESS+
StatusNot Yet Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Hepatitis C is a common and potentially serious disease. However, there are treatments that can cure it. That's why it's so important to detect the hepatitis C virus (HCV) and treat those affected. Today, many hepatitis C sufferers in Cameroon (and elsewhere) remain untreated. The aim of this research is therefore to evaluate a simplified screening and treatment strategy (developed specifically for the Cameroonian context) in comparison with a standard strategy (based on usual care), in order to improve access to hepatitis C treatment in Cameroon. If the results of this research are positive, this strategy could be recommended to health authorities in Cameroon and other comparable countries.
Trial Details
NCT Number NCT07098481
Lead Sponsor ANRS, Emerging Infectious Diseases
Collaborators: IRD, Epidemiologie et Prevention, Montpelier, France, SESSTIM (IRD, Inserm, Université Aix-Marseille), Centre de Recherche sur les Maladies Emergentes et Re-Emergentes (CREMER), Faculté de Médecine et des Sciences Biomédicales, Université de Yaoundé I, Yaoundé, Cameroun, PharmAccess, Service d'hépato-gastroentérologie, Hôpital Saint Joseph, Marseille, France
Conditions
(from sponsor)		 Hepatitis C Virus Infection
Related terms Hepatitis C
Enrollment 576 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov